PCG Wealth Advisors’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$450K Sell
1,153
-41
-3% -$17.3K 0.1% 122
2026
Q1
$565K Sell
1,194
-15
-1% -$7.55K 0.14% 106
2025
Q4
$564K Sell
1,209
-43
-3% -$20K 0.16% 96
2025
Q3
$534K Hold
1,252
0.16% 98
2025
Q2
$480K Sell
1,252
-32
-2% -$11.5K 0.25% 57
2025
Q1
$444K Buy
1,284
+42
+3% +$13.5K 0.15% 92
2024
Q4
$373K Hold
1,242
0.14% 99
2024
Q3
$505K Hold
1,242
0.19% 80
2024
Q2
$399K Hold
1,242
0.17% 80
2024
Q1
$414K Buy
1,242
+71
+6% +$21.7K 0.2% 76
2023
Q4
$317K Hold
1,171
0.18% 77
2023
Q3
$288K Hold
1,171
0.19% 79
2023
Q2
$355K Sell
1,171
-45
-4% -$12.5K 0.22% 76
2023
Q1
$321K Buy
1,216
+81
+7% +$20.6K 0.2% 80
2022
Q4
$272K Sell
1,135
-1,123
-50% -$252K 0.17% 83
2022
Q3
$414K Buy
+2,258
New +$450K 0.15% 82
2022
Q2
Sell
-1,129
Closed -$283K 93
2022
Q1
$283K Buy
1,129
+55
+5% +$13.8K 0.18% 69
2021
Q4
$276K Buy
+1,074
New +$263K 0.19% 64

Other funds holding HCA

PCG Wealth Advisors's HCA Position: Q2 2026 in Review

PCG Wealth Advisors reduced its HCA Healthcare (HCA) stake by 3.4% in Q2 2026, selling an estimated $17.3K and leaving 1,153 shares worth $450K. The position accounts for 0.1% of the portfolio, ranked #122.

PCG Wealth Advisors first reported a position in HCA in Q4 2021 and has held it in 18 quarters since. The position peaked at $565K in Q1 2026. 1,333 funds tracked by Wall St. Rank hold HCA as of Q2 2026.

  • PCG Wealth Advisors held 1,153 shares of HCA Healthcare worth $450K as of Q2 2026.
  • PCG Wealth Advisors sold 41 HCA Healthcare shares in Q2 2026, an estimated $17.3K.
  • HCA Healthcare made up 0.1% of PCG Wealth Advisors's portfolio in Q2 2026, its #122 holding.
  • PCG Wealth Advisors first reported a position in HCA Healthcare in Q4 2021 and has held it in 18 quarters since.
  • PCG Wealth Advisors's HCA Healthcare position peaked at $565K in Q1 2026.
  • 1,333 funds tracked by Wall St. Rank held HCA Healthcare as of Q2 2026.

Based on PCG Wealth Advisors's 13F filing for Q2 2026, filed 3 Aug 2026.